B97. RISKY BUSINESS: TREATMENTS AND CLINICAL TARGETS IN PULMONARY HYPERTENSION

查看最新文献

147

B97. RISKY BUSINESS: TREATMENTS AND CLINICAL TARGETS IN PULMONARY HYPERTENSION - 最新文献

"Super-responders" in Pulmonary Arterial Hypertension: An Individual Participant Data Meta-analysis

Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4236 Hao Pan, W. Yang, J. Moutchia, R. McClelland, D. Appleby, J. Minhas, S. Pugliese, A. Smith, N. Al-Naamani, S. Kawut

Remodulin Induction Facilitates Rapid Achievement of Therapeutic Doses of Oral Treprostinil: Results From the EXPEDITE Study

Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4237 J. Kingrey, C. E. Miller, V. Balasubramanian, R. Zolty, R. Oudiz, J. Elwing, L. Melendres‐Groves, J.S. Smith, A. Ravichandran, J. Tarver, D. Johnson, S. Seaman, C. Thrasher, M. Broderick, V. Franco

Alpha Study: Pulmonary Arterial Hypertension Treated With Cardiosphere-derived Allogeneic Stem Cells

Pub Date : 2023-05-01 DOI: 10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4233 M. Lewis, S. Shapiro, R. Oudiz, M. Nakamura, D. Geft, Y. Matusov, A. Hage, V. Tapson, P. Azizad-Pinto, T. Henry, R. Saggar, J. Mirocha, J. V. Van Eyk, E. Marbán

查看全部

免责声明：
本页显示期刊或杂志信息，仅供参考学习，不是任何期刊杂志官网，不涉及出版事务，特此申明。如需出版一切事务需要用户自己向出版商联系核实。若本页展示内容有任何问题，请联系我们，邮箱：info@booksci.cn，我们会认真核实处理。